Taher F, Assadian O, Hirsch K, Falkensammer J, Senekowitsch C, Assadian A
Abteilung für Vaskuläre und Endovaskuläre Chirurgie, Wilhelminenspital Wien, Montleartstr. 37, Pavillon 30B, A-1160, Wien, Österreich,
Chirurg. 2015 Mar;86(3):293-302. doi: 10.1007/s00104-015-3009-x.
Vascular prosthesis infections are potentially severe adverse events following vascular reconstruction. They are often associated with a high morbidity and mortality, especially in the aortofemoral region. The present article outlines the diagnosis, prevention and treatment of vascular graft infections in a clinical setting. The clinical presentation, inflammatory markers, microbiological work-up and imaging studies can contribute to diagnosing a prosthesis infection. Regarding the bacterial spectrum involved in the etiology of prosthesis infections, single organism infections (monoinfections) have become less significant over the past years, whereas infections with multiple organisms now constitute the most abundant microbiological constellation. Also, infections with resistant bacterial strains have been increasing in number over the past years and deserve special consideration. It remains unclear whether both aspects are due to a true epidemiological change or are the result of advanced molecular microbiological diagnostic methods. While during the past decades perioperative antibiotic prophylaxis was regarded as the most important measure for preventing prosthesis infections in vascular surgery, other primary preventive hygiene strategies have been increasingly explored and grouped together in the sense of preventive bundles. In most cases of deep postoperative infections involving a prosthetic device in the aortofemoral region, explantation of the prosthesis will be required. In situ and extra-anatomical reconstructions are often performed in such cases and the decision process to develop an optimal treatment plan must consider several individual factors. In select patients, palliative preservation of the prosthesis despite surrounding infection (i.e. graft salvage) and best conservative management in combination with local surgical measures, such as incision and drainage and vacuum therapy, deserve consideration as a treatment option for patients with a high surgical risk.
血管假体感染是血管重建术后潜在的严重不良事件。它们通常与高发病率和死亡率相关,尤其是在主-股动脉区域。本文概述了临床环境中血管移植物感染的诊断、预防和治疗。临床表现、炎症标志物、微生物学检查和影像学研究有助于诊断假体感染。关于假体感染病因中涉及的细菌谱,在过去几年中,单一生物体感染(单菌感染)的重要性已降低,而多种生物体感染现在构成了最常见的微生物组合。此外,过去几年中耐菌株感染的数量一直在增加,值得特别关注。目前尚不清楚这两个方面是由于真正的流行病学变化还是先进的分子微生物诊断方法的结果。在过去几十年中,围手术期抗生素预防被视为血管外科预防假体感染的最重要措施,而其他主要的预防性卫生策略已得到越来越多的探索,并在预防性综合措施的意义上进行了整合。在大多数涉及主-股动脉区域假体装置的深部术后感染病例中,需要取出假体。在这种情况下,通常会进行原位和解剖外重建,制定最佳治疗方案的决策过程必须考虑几个个体因素。对于一些患者,尽管假体周围存在感染,但姑息性保留假体(即移植物挽救)以及结合局部手术措施(如切开引流和负压治疗)的最佳保守治疗,作为手术风险高的患者的一种治疗选择值得考虑。